Skip to content

Omega-3 Fatty Acids Plus Vitamin E Cosupplementation Versus Vitamin E in Fibrocystic Breast Patient

Omega-3 Fatty Acids Plus Vitamin E Cosupplementation Versus Vitamin E in Fibrocystic Breast Patient

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04694027
Acronym
FCC
Enrollment
120
Registered
2021-01-05
Start date
2021-01-31
Completion date
2021-03-31
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastalgia

Brief summary

to identify the effect of omega-3 plus vitamin E cosupplementation on mastalgia in patients with FCC and to compare its effect with that of vitamin E only.

Detailed description

120 patients will be enrolled in the study and divided into three groups each group consisted 40 patient then the severity of mastalgia in the three groups before, through and after intervention. Radiological assessment was done before and after the intervention.

Interventions

DRUGOmega 3 fatty acid

omega 3 1000 mg

DRUGVitaE

vitamin e 400 mg

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* all females with mastalgia aged 18 to 55

Exclusion criteria

Pregnant and lactating women, patient who had a recent breast abscess or breast drainage, patient used omega-3 and vitamin E supplementation before the trial and postmenopausal women. \-

Design outcomes

Primary

MeasureTime frameDescription
improvement of pain severity3 monthsimprovement of pain on visual analogue scale

Secondary

MeasureTime frame
improvement of radiological finding3 months

Countries

Egypt

Contacts

Primary ContactRehab Sabry
rehab.yassen@kasralainy.edu.eg0201063314476
Backup ContactHeba El nahas
hebagalal@kasralainy.edu.eg020104810684

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026